middle.news
Vitrafy cuts losses by half with $3.66m revenue and US military validation
8:22am on Tuesday 4th of August, 2026 AEST
•
Healthcare
Read Story
Vitrafy cuts losses by half with $3.66m revenue and US military validation
8:22am on Tuesday 4th of August, 2026 AEST
Key Points
80% revenue growth to $3.66 million
Net loss halved to $16.17 million
US Army Phase II platelet study delivers 94.4% recovery
Partnerships with Vitalant and Hoxworth blood centers
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE